Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ján, Staško"'
Autor:
Monika Péčová, Jakub Benko, Martin Jozef Péč, Tomáš Bolek, Tatiana Hurtová, Juraj Sokol, Ján Staško, Matej Samoš, Marián Mokáň
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-4 (2024)
Abstract Background Although stroke and acute limb ischemia seem easily distinguishable by anamnesis and physical examination, symptoms may overlap and sometimes mislead the examiner. Such a situation can arise in the occurrence of unilateral neurolo
Externí odkaz:
https://doaj.org/article/cba4fbadd4544c46b151567469d15f57
Autor:
Lucia Stančiaková, Kristína Brisudová, Ingrid Škorňová, Tomáš Bolek, Matej Samoš, Kamil Biringer, Ján Staško, Juraj Sokol
Publikováno v:
Pharmaceuticals, Vol 17, Iss 6, p 773 (2024)
Venous thromboembolism (VTE) represents one of the leading causes of death during pregnancy. The greatest risk for it is the presence of medical or family history of VTE, stillbirth, cesarean section and selected thrombophilia. Appropriate thrombopro
Externí odkaz:
https://doaj.org/article/9469e3dbb39448d7a4dadd5419064cdc
Autor:
Alena Strýčková, Jakub Benko, Martin Jozef Péč, Monika Péčová, Jana Žolková, Monika Brunclíková, Tomáš Bolek, Ján Staško, Matej Samoš, Marián Mokáň
Publikováno v:
Case Reports in Hematology, Vol 2022 (2022)
Coronavirus disease 2019 (COVID-19) is an acute complex systemic disorder caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).While SARS-CoV-2 is known to cause significant pulmonary disease, various extrapulmonary manifestatio
Externí odkaz:
https://doaj.org/article/9b93ec6332e74a32afc4d8247bcb9628
Autor:
Ingrid Škorňová, Matej Samoš, Tomáš Bolek, Lucia Stančiaková, Ľubica Vádelová, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)
Abstract Atorvastatin and direct oral factor Xa inhibitors (xabans) are frequently co‐administrated in patients with atrial fibrillation (AF). However, no studies investigating the possibility of the pharmacologic interaction between these agents h
Externí odkaz:
https://doaj.org/article/b80471fb545746388efc3792ab8b5bc4
Autor:
Ivar, Vacula, Zuzana, Rusiňáková, Denisa, Čelovská, Peter, Jackuliak, Ján, Slopovský, Patrik, Palacka, Matej, Moščovič, Stanislav, Špánik, Ján, Staško, Alexander, Wild, Angelika, Bátorová, Juraj Ma, Arič
Publikováno v:
Vnitřní lékařství. 68:221-226
The increasing volume of the data and experience with direct oral anticoagulants (DOACS) in the primary and secondary prevention of venous thromboembolism in oncologic patients (CAVTE) has recently lead to changes in several international guidelines.
Autor:
Dana Prídavková, Matej Samoš, Tomáš Bolek, Ingrid Škorňová, Jana Žolková, Peter Kubisz, Ján Staško, Marián Mokáň
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Type 2 diabetes (T2D) is an independent risk factor of stroke and systemic embolism in patients with atrial fibrillation (AF), and T2D patients with AF-associated stroke seem to have worse clinical outcome and higher risk of unfavorable clinical cour
Externí odkaz:
https://doaj.org/article/65a50962082648c3a0445471b3c7e0aa
Autor:
Matej Samoš, Ingrid Škorňová, Tomáš Bolek, Lucia Stančiaková, Barbora Korpallová, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň
Publikováno v:
Diagnostics, Vol 11, Iss 1, p 143 (2021)
Platelets play crucial role in acute vascular atherosclerotic diseases, including myocardial infarction and stroke. Additionally, platelet aggregation is a key target of antiplatelet agents, forming the keystone of pharmacotherapy of various atherosc
Externí odkaz:
https://doaj.org/article/32c16b71f4a84d06983c2229c742443b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tomáš Bolek, Matej Samoš, Jakub Jurica, Lucia Stančiaková, Martin Jozef Péč, Ingrid Škorňová, Peter Galajda, Ján Staško, Marián Mokáň, Peter Kubisz
Publikováno v:
Journal of Clinical Medicine. 12:2038
The coronavirus SARS-CoV2 disease (COVID-19) is connected with significant morbidity and mortality (3.4%), disorders in hemostasis, including coagulopathy, activation of platelets, vascular injury, and changes in fibrinolysis, which may be responsibl
Autor:
Matej Samoš, Marián Fedor, František Kovář, Peter Galajda, Tomáš Bolek, Lucia Stančiaková, Jana Fedorová, Ján Staško, Peter Kubisz, Marián Mokáň
Publikováno v:
Journal of Diabetes Research, Vol 2016 (2016)
Background. The aim of this study was to validate the impact of type 2 diabetes (T2D) on the platelet reactivity in patients with acute ST elevation myocardial infarction (STEMI) treated with adenosine diphosphate (ADP) receptor blockers. Methods. A
Externí odkaz:
https://doaj.org/article/11ead8647d6449a9807034a6e8624e97